Lungs News and Research

RSS

Studies investigate end-of-life healthcare

Patients with advanced cancer who discuss end-of-life care with their physicians appear to have lower health care costs in the final week of life than those who do not, according to a report in the March 9 issue of Archives of Internal Medicine.

10 Mar 2009

Metastatic bone disease patients can walk in Lazarus' footsteps

Osteoplasty - a highly effective minimally invasive procedure to treat the painful effects of metastatic bone disease by injecting bone cement to support weakened bones - provides immediate and substantial pain relief, often presenting individuals who are suffering terribly with the miraculous so-called "Lazarus effect," according to researchers at the Society of Interventional Radiology's 34th Annual Scientific Meeting.

10 Mar 2009

Helium/oxygen mix helps lung patients breathe easier

New research published in the international journal Chest , by Neil Eves, PhD, finds that people with chronic obstructive pulmonary disease (COPD) who breathed a mix of 60% helium and 40% oxygen during a rehabilitation program were able to exercise longer and harder than those who breathed normal air.

10 Mar 2009

New procedure for eliminating reblockage of arteries

An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.

10 Mar 2009

Variants in DNA repairing genes may influence risk of Hodgkin disease

A new analysis has found that certain variations in genes that repair DNA can affect a person's risk of developing Hodgkin disease.

10 Mar 2009

City kids may breathe easier in the country

Children with asthma have an easier time breathing if they spend even a few days in the country, safeguarded from urban air pollution, a study led by Giovanni Piedimonte, M.D., professor and chairman of the Department of Pediatrics at the West Virginia University School of Medicine, finds.

10 Mar 2009

Azaya Therapeutics selected for Nanotechnology Characterization Lab by National Cancer Institute

Azaya Therapeutics, Inc. has announced that it has been selected by the National Cancer Institute (NCI) for a research collaboration to study Azaya's lead cancer therapy, ATI - 1123.

10 Mar 2009

Breakthrough improves effectiveness of tuberculosis vaccine

A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine 's Advance Online Publication March 1.

8 Mar 2009

Advances in stem cell research

Scientists at The University of Texas Health Science Center at Houston are on the forefront of stem cell research, developing novel therapies designed to generate heart cells, repair traumatic lung injuries, grow new bone and stanch the spread of cancer cells.

8 Mar 2009

Abdominal obesity puts the squeeze on lungs

There's more bad news for people who carry excess weight around their waists: Not only is abdominal obesity associated with diabetes, hypertension, cardiovascular disease and a host of other health problems collectively known as "metabolic syndrome," a new study has found that a high waist circumference is strongly associated with decreased lung function-independent of smoking history, sex, body mass index (BMI) and other complicating factors.

8 Mar 2009

Pulmonary hypertension in children may result from reduced activity of gene regulator

Too little activity by gene regulators called PPARs appears to be a major player in the irreversible lung damage that can occur in children with heart defects, researchers say.

5 Mar 2009

Cultured stem cells and bioengineered skin used to successfully treat scleroderma

Scleroderma is an autoimmune disease that leads to thickening and severe scarring of skin as well as thickening and failure of internal organs, including the lungs, heart, kidneys and intestines.

5 Mar 2009

New study using combination of bioengineered skin and stem cells shows promise in treatment of non-healing wounds

Scleroderma is an autoimmune disease that leads to thickening and severe scarring of skin as well as thickening and failure of internal organs, including the lungs, heart, kidneys and intestines.

5 Mar 2009

Patented inventions double at University at Buffalo

An antibody with the potential to stop breast cancer in its path. A nanoparticle that can address a side effect of the treatment that hemophiliacs cannot live without. A "quantum dot" with the potential to treat cancer or harvest the power of the sun. An air purifier that kills the world's nastiest toxins.

5 Mar 2009

Stereotactic body radiotherapy doubles survival in lung cancer

Countless people have heard the phrase, "You have lung cancer," but only 50 can say they've completed a new treatment at Temple University that doubles their chances of surviving the deadly disease - and without the conventional radiation regimen or surgery.

4 Mar 2009

Study offers clues to beating hearing loss

Researchers at the University of Leeds have made a significant step forward in understanding the causes of some forms of deafness.

4 Mar 2009

Black women in UK have double risk of complications during pregnancy

In the UK, black Caribbean and black African women have twice as much risk of experiencing severe pregnancy complications than white women, according to research published on BMJ.com.

3 Mar 2009

Pharmaxis announces NDA filing for Aridol

Pharmaxis, Inc., a wholly owned subsidiary of Pharmaxis Ltd , an emerging respiratory specialty pharmaceutical company, announced today that it has filed a New Drug Application (NDA), electronically, with the U.S. Food and Drug Administration (FDA) for Aridol (mannitol bronchial challenge test).

3 Mar 2009

Persistent Electronic Warnings Push Some Smokers to Quit

The more smokers worry about health risks, the more they will contemplate quitting, according to a new study in the latest issue of the journal Annals of Behavioral Medicine. Warning messages create worry that can nudge smokers down that road, the researchers concluded.

3 Mar 2009

Aerovance starts trial of Aerovant for uncontrolled asthma

Aerovance Inc. has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial(TM), of inhaled dry powder Aerovant in patients with uncontrolled asthma.

3 Mar 2009